quinidine
DISEASE INTERVENTION COMPARISON RESULTS
Nord Med. 1968 Jun 13; 79(24): 781-2 Controlled Clinical Trial
IN StudyID: Aberg 1969 (subordinated publication), atrial fibrillation The Use of
procaine amide quinidine (?)
As Treatment, Chronic
Is not available Than
not available
To AF recurrence
Nord Med. 1969 Aug 14;82(33):1011-3 Controlled Clinical Trial
IN StudyID: Aberg 1969, atrial fibrillation The Use of
procaine amide quinidine (?)
As Treatment, Chronic
Is not available Than
not available
To not available
Rev Esp Cardiol. 1978;31(1 Pt 2):185-91 Randomized Controlled Trial
IN StudyID: Aros 1978, atrial fibrillation The Use of
quinidine plus amiodarone
As Treatment, Chronic
Is better Than
quinidine alone
To not available
Eur Heart J. 1981 Feb; 2(1): 49-55 not available
IN StudyID: Boissel 1981, atrial fibrillation The Use of
quinidine
As Treatment, Chronic
Is - Than
not available
To not available
Br Heart J 1970 May;32(3):370-6 Randomized Controlled Trial
IN StudyID: Byrne-Quinn 1970, atrial fibrillation The Use of
quinidine
As Treatment, Chronic
Is better Than
placebo
To recurrence of symptomatic arrhythmia, adverse effects, proarrhythmia, mortality - at 12 months
Circulation. 1990 Oct;82(4):1106-16 Meta-Analysis
IN StudyID: Coplen 1990, atrial fibrillation, pro-arrhythmia The Use of
quinidine
As Treatment, Chronic
Is worse Than
placebo
To overall unajusted mortality at 1 year: 2.9% in intv. vs 0.8% in cont. Patients remaining in sinus rhythm at 1 year were: 50% in intv. vs 24% in cont.
Arch Inst Cardiol Mex. 1971 May-Jun; 41(3): 278-84 Not available
IN StudyID: Cuan-Perez 1971, atrial fibrillation The Use of
quinidine, diphenylhydantoin
As Treatment, Chronic
Is - Than
propranolol
To Not available
Die Medizinische Welt. 1969;20(25):1464 not available
IN StudyID: Hartel 1970 (subordinated publication), atrial fibrillation The Use of
quinidine
As Treatment, Chronic
Is not available Than
not available
To not available
Klinische Wochenschrift. 1969;47(17):942 not available
IN StudyID: Hartel 1970 (subordinated publication), atrial fibrillation The Use of
quinidine
As Treatment, Chronic
Is not available Than
not available
To not available
Br Heart J 1970 Jan;32(1):57-60 not available
IN StudyID: Hartel 1970, atrial fibrillation The Use of
quinidine
As Treatment, Chronic
Is - Than
not available
To not available
Br Heart J 1971 Jul;33(4):518-21 Controlled Clinical Trial
IN StudyID: Hillestad 1971, atrial fibrillation The Use of
quinidine
As Treatment, Chronic
Is better Than
no treatment
To recurrence of symptomatic arrhythmia, adverse effects, proarrhythmia, mortality - at 12 months
J Am Coll Cardiol. 1995 Oct;26(4):852-8 Randomized Controlled Trial
IN StudyID: Hohnloser 1995, atrial fibrillation, persistent The Use of
quinidine
As Treatment, Chronic
Is equal Than
sotalol
To AF recurrence, proarrhythmia, adverse effects - at 6 months
Minerva Cardioangiol. 1973 Oct; 21(10): 668-71 Clinical Trial
IN StudyID: Levi 1973 (subordinated publication), atrial fibrillation The Use of
quinidine
As Treatment, ?
Is - Than
practolol
To Not available
Cardiology. 1973; 58(6): 364-8 Randomized Controlled Trial
IN StudyID: Levi 1973, atrial fibrillation The Use of
quinidine plus beta-blocker (practolol)
As Treatment, Acute
Is equal Than
quinidine alone
To acute pharmacological cardioversion of AF
S Afr Med J 1984 Mar 10;65(10):367-9 Randomized Controlled Trial
IN StudyID: Lloyd 1984, atrial fibrillation The Use of
quinidine, disopyramide
As Treatment, Chronic
Is equal Than
placebo
To mortality, stroke, AF recurrence, adverse effects, pro-arrhythmia - at 6 months
Circulation. 1991 Nov;84(5):1977-83 Meta-Analysis
IN StudyID: Morganroth 1991, ventricular tachycardia, antiarrhythmics mortality The Use of
quinidine
As Treatment, Chronic
Is worse Than
other class I antiarrhythmic drugs
To modify mortality: 2.3% quinidine VS 0.7% other class I drugs, p=0.05
Z Kardiol 1999 Mar;88(3):195-207 Randomized Controlled Trial
IN StudyID: PAFAC (subordinated publication), atrial fibrillation, persistent The Use of
quinidine, sotalol
As Treatment, Chronic
Is - Than
placebo
To mortality, AF recurrence - at 12 months
Eur Heart J. 2004 Aug;25(16):1385-94 Randomized Controlled Trial
IN StudyID: PAFAC, atrial fibrillation, persistent The Use of
quinidine, sotalol
As Treatment, Chronic
Is better Than
placebo
To mortality, adverse effects, pro-arrhythmia, AF recurrence - at 12 months
Acta Med Scand Suppl. 1981; 645: 23-8 Cross-Over, Randomized Controlled Trial
IN StudyID: Rasmussen 1981, atrial fibrillation, rejected The Use of
quinidine
As Treatment, Chronic
Is better Than
verapamil
To AF recurrence, adverse effects, sudden death
Br Heart J 1971 Mar;33(2):220-5 Clinical Trial (non-controlled, non-randomized)
IN StudyID: Resnekov 1971, atrial fibrillation The Use of
quinidine
As Treatment, Chronic
Is equal Than
no treatment
To avoid AF recurrence, and worse for adverse effects
Prog Cardiovasc Dis. 2001 Sep-Oct;44(2):121-52 Meta-Analysis
IN StudyID: Slavik 2001, atrial fibrillation The Use of
IV procainamide, oral quinidine, oral flecainide, oral propafenone, IV or hight-dose oral amiodarone, IV ibutilide
As Treatment, Acute
Is better Than
placebo
To converting AF to sinus rhythm
Br Heart J 1975 May;37(5):486-92 Randomized Controlled Trial
IN StudyID: Sodermark 1975, atrial fibrillation The Use of
quinidine
As Treatment, Chronic
Is better Than
no treatment
To AF recurrence, adverse effects - at 12 months
Z Kardiol (Zeitschrift fur Kardiologie) 1999 Mar;88(3):185-94 Randomized Controlled Trial
IN StudyID: SOPAT (subordinated publication), atrial fibrillation, paroxysmal The Use of
quinidine, sotalol
As Treatment, Chronic
Is - Than
placebo
To at 12 months: AF recurrence, adverse effects, pro-arrhythmia, mortality
Eur Heart J. 2004 Aug;25(16):1395-404 Randomized Controlled Trial
IN StudyID: SOPAT, atrial fibrillation, paroxysmal The Use of
quinidine, sotalol
As Treatment, Chronic
Is better Than
placebo
To at 12 months: AF recurrence, adverse effects, pro-arrhythmia, mortality
Dtsch Med Wochenschr. 1988 Dec 2;113(48):1867-71 Randomized Controlled Trial
IN StudyID: Steinbeck 1988, atrial fibrillation, paroxysmal The Use of
flecainide, quinidine
As Treatment, Chronic
Is better Than
placebo
To AF recurrence, adverse affects - at 11 months